Ivan M. Robbins

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

Richard N. Channick, G Simonneau, Olivier Sitbon et al. · The Lancet · 2001 · 1.5K citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +10

Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

David B. Badesch, Victor F. Tapson, Michael D. McGoon et al. · Annals of Internal Medicine · 2000 · 1.1K citations

Sitaxsentan Therapy for Pulmonary Arterial Hypertension

Robyn J. Barst, David Langleben, Adaani Frost et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 705 citations

Endothelin-b Receptors, Hypertension, Pulmonary Arterial Hypertension +14

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2

Marc Humbert, Robyn J. Barst, Ivan M. Robbins et al. · European Respiratory Journal · 2004 · 638 citations · Full text

Beraprost therapy for pulmonary arterial hypertension

Robyn J. Barst, Michael D. McGoon, Vallerie V. McLaughlin et al. · Journal of the American College of Cardiology · 2003 · 629 citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +9